
The order effectively brings several popular cough syrups, painkillers and cold medication out of the health ministry’s impending ban list, providing relief to drug companies pegged at over Rs 740 crore annually.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MZV6Va
via
IFTTT
0 comments:
Post a Comment